CS logo
small CS logo
NewLab Clinical Research Inc.

St Johns, Newfoundland and Labrador, Canada
Research foundation in St. John's, Newfoundland and Labrador
187 Lemarchant Rd, St. John's, NL A1C 2H5

About NewLab Clinical Research Inc.


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Pfizer
4
Galderma R&D
3
Asana BioSciences
2
Innovaderm Research Inc.
2
LEO Pharma
2
Amgen
1
Astellas Pharma Global Development, Inc.
1
Astellas Pharma Inc
1
Boehringer Ingelheim
1
Cipher Pharmaceuticals Inc.
1
Dow Pharmaceutical Sciences
1
Total Rows: 13

Clinical Trials at NewLab Clinical Research Inc.


During the past decade, NewLab Clinical Research Inc. conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 5 clinical trials were completed, i.e. on average, 166.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years22110011Started TrialsCompleted Trails201820190123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Calcitriol BID Topical Treatment in Adolescents With Plaque Psoriasis
2006-08-01
2009-09-24
Completed
25
A Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris
2006-10-01
2007-12-01
Completed
1,670
Treatment of Mild to Moderate Distal Subungual Onychomycosis of the Toenail
2007-01-01
2008-10-01
Completed
443
Assessment and Tracking of Long-term Alefacept Safety
2003-06-01
2012-02-01
Terminated
1,897
A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
2005-05-25
2019-01-31
Terminated
8,071
A Phase II Study of MEDI-507, Administered by Injection to Adults With Psoriasis
2001-09-01
2003-07-01
Completed
420
Topical CP-690,550 For Chronic Plaque Psoriasis
2008-10-13
2009-07-24
Completed
81
Safety and Efficacy of Adalimumab in Patients Who Showed an Unsatisfactory Response to Etanercept
2007-03-01
2008-12-01
Completed
85

Rows per page:

1–21 of 21

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "NewLab Clinical Research Inc." #1 sponsor was "Pfizer" with 4 trials, followed by "Galderma R&D" with 3 trials sponsored, "Asana BioSciences" with 2 trials sponsored, "Innovaderm Research Inc." with 2 trials sponsored and "LEO Pharma" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "NewLab Clinical Research Inc." #1 collaborator was "Abbott" with 1 trials as a collaborator, "Amgen" with 1 trials as a collaborator and "Kyowa Kirin Co., Ltd." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.
Created with Highcharts 11.1.0Top Leading SponsorsPfizer: 4Pfizer: 4Galderma R&D: 3Galderma R&D: 3Asana BioSciences: 2Asana BioSciences: 2Innovaderm Research Inc.: 2Innovaderm Research Inc.: 2LEO Pharma: 2LEO Pharma: 2Amgen: 1Amgen: 1Astellas Pharma GlobalDevelopment, Inc.: 1Astellas Pharma GlobalDevelopment, Inc.: 1Astellas Pharma Inc: 1Astellas Pharma Inc: 1Boehringer Ingelheim: 1Boehringer Ingelheim: 1Cipher Pharmaceuticals Inc.: 1Cipher Pharmaceuticals Inc.: 1

Created with Highcharts 11.1.0Top CollaboratorsAbbott: 1Abbott: 1Amgen: 1Amgen: 1Kyowa Kirin Co., Ltd.: 1Kyowa Kirin Co., Ltd.: 1

Clinical Trials Conditions at NewLab Clinical Research Inc.


According to Clinical.Site data, the most researched conditions in "NewLab Clinical Research Inc." are "Psoriasis" (7 trials), "Atopic Dermatitis" (3 trials), "Plaque Psoriasis" (3 trials), "Onychomycosis" (2 trials) and "Acne Vulgaris" (1 trials). Many other conditions were trialed in "NewLab Clinical Research Inc." in a lesser frequency.

Clinical Trials Intervention Types at NewLab Clinical Research Inc.


Most popular intervention types in "NewLab Clinical Research Inc." are "Drug" (20 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "CP-690,550" (4 trials), "ASN002" (2 trials), "ASKP1240" (1 trials) and "Adalimumab Every Week" (1 trials). Other intervention names were less common.

Clinical Trials Genders at NewLab Clinical Research Inc.


The vast majority of trials in "NewLab Clinical Research Inc." are 21 trials for "All" genders.

Clinical Trials Status at NewLab Clinical Research Inc.


Currently, there are NaN active trials in "NewLab Clinical Research Inc.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in NewLab Clinical Research Inc., undefined suspended trials, and 4 terminated clinical trials to date.
Out of the total trials that were conducted in NewLab Clinical Research Inc., 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 9Phase 2: 9Phase 3: 9Phase 3: 9Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 17Completed: 17Terminated: 4Terminated: 4